chr1-218349683-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003238.6(TGFB2):c.346+2636A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0585 in 152,354 control chromosomes in the GnomAD database, including 347 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.059   (  347   hom.,  cov: 33) 
Consequence
 TGFB2
NM_003238.6 intron
NM_003238.6 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.770  
Publications
9 publications found 
Genes affected
 TGFB2  (HGNC:11768):  (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016] 
TGFB2 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Loeys-Dietz syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.125  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TGFB2 | NM_003238.6 | c.346+2636A>G | intron_variant | Intron 1 of 6 | ENST00000366930.9 | NP_003229.1 | ||
| TGFB2 | NM_001135599.4 | c.346+2636A>G | intron_variant | Intron 1 of 7 | NP_001129071.1 | |||
| TGFB2 | NR_138148.2 | n.1712+2636A>G | intron_variant | Intron 1 of 6 | ||||
| TGFB2 | NR_138149.2 | n.1712+2636A>G | intron_variant | Intron 1 of 7 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB2 | ENST00000366930.9 | c.346+2636A>G | intron_variant | Intron 1 of 6 | 1 | NM_003238.6 | ENSP00000355897.4 | |||
| TGFB2 | ENST00000366929.4 | c.346+2636A>G | intron_variant | Intron 1 of 7 | 1 | ENSP00000355896.4 | ||||
| TGFB2 | ENST00000488793.1 | n.10+2636A>G | intron_variant | Intron 1 of 2 | 3 | 
Frequencies
GnomAD3 genomes  0.0585  AC: 8905AN: 152236Hom.:  345  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
8905
AN: 
152236
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0585  AC: 8913AN: 152354Hom.:  347  Cov.: 33 AF XY:  0.0615  AC XY: 4580AN XY: 74510 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
8913
AN: 
152354
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
4580
AN XY: 
74510
show subpopulations 
African (AFR) 
 AF: 
AC: 
559
AN: 
41584
American (AMR) 
 AF: 
AC: 
1138
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
167
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
691
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
434
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
1173
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
13
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4525
AN: 
68030
Other (OTH) 
 AF: 
AC: 
124
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 433 
 867 
 1300 
 1734 
 2167 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 110 
 220 
 330 
 440 
 550 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
414
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.